Advanced search
1 file | 153.68 KB Add to list

Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects

Author
Organization
Abstract
Objective: The authors conducted a prospective study of neurodegenerative and vascular dementia in Belgium. Strict diagnostic inclusion criteria were used to include well defined patients and controls. The results of apolipoprotein E (APOE) genotype effect on risk and clinical characteristics are presented. Methods: APOE genotyping was performed in patients with probable Alzheimer's disease (AD) (n=504), frontotemporal dementia (FTD) (n=47), vascular dementia (VaD) (n=152), mixed dementia (n=132), mild cognitive impairment (MCI) (n=44), Parkinson's disease (PD) (n=30), dementia with Lewy bodies (DLB) (n=17), and multisystem atrophy (MSA)/progressive supranuclear palsy (PSP) (n=12). Results: The APOE allele frequencies of this Belgian control population (epsilon2: 6.9%; epsilon3: 76.2%; epsilon4: 16.9%) did not differ from those reported for other white populations. AD, MCI, and mixed dementia patients had higher APOE epsilon4 (32.9%, 38.6%, and 28.4% respectively) and lower APOE epsilon3 (62.2%, 53.4%, and 66.3%) frequencies compared with controls, whereas only AD and mixed dementia patients had lower APOE epsilon2 frequencies (4.9% and 5.3%). Apart from a borderline significant different distribution of APOE allele frequencies in VaD patients compared with controls, no other differences were detected. The influence of APOE epsilon4 on clinical features of dementia was limited to lower age at onset in AD patients and a less pronounced negative correlation between age at onset and number of epsilon4 alleles in MCI and mixed dementia patients. Conclusions: This study confirmed the risk association between APOE epsilon4 and AD. The observation that APOE epsilon4 is associated with mixed dementia reflected the role of AD in the aetiopathogenesis of this condition. Although MCI is an aetiologically heterogeneous syndrome, the increased APOE epsilon4 frequencies indicated that a large proportion of the MCI patients included in the study might be predisposed to develop AD.
Keywords
ONSET ALZHEIMERS-DISEASE, APOLIPOPROTEIN-E EPSILON-4, FRONTOTEMPORAL DEMENTIA, E4 ALLELE, E GENE, RISK, ASSOCIATION, DECLINE, AGE

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 153.68 KB

Citation

Please use this url to cite or link to this publication:

MLA
Engelborghs, S., et al. “Prospective Belgian Study of Neurodegenerative and Vascular Dementia: APOE Genotype Effects.” JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, vol. 74, no. 8, 2003, pp. 1148–51, doi:10.1136/jnnp.74.8.1148.
APA
Engelborghs, S., Dermaut, B., Goeman, J., Saerens, J., Marien, P., Pickut, B., … De Deyn, P. (2003). Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 74(8), 1148–1151. https://doi.org/10.1136/jnnp.74.8.1148
Chicago author-date
Engelborghs, S, Bart Dermaut, J Goeman, J Saerens, P Marien, BA Pickut, M Van den Broeck, et al. 2003. “Prospective Belgian Study of Neurodegenerative and Vascular Dementia: APOE Genotype Effects.” JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY 74 (8): 1148–51. https://doi.org/10.1136/jnnp.74.8.1148.
Chicago author-date (all authors)
Engelborghs, S, Bart Dermaut, J Goeman, J Saerens, P Marien, BA Pickut, M Van den Broeck, S Serneels, M Cruts, C Van Broeckhoven, and PP De Deyn. 2003. “Prospective Belgian Study of Neurodegenerative and Vascular Dementia: APOE Genotype Effects.” JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY 74 (8): 1148–1151. doi:10.1136/jnnp.74.8.1148.
Vancouver
1.
Engelborghs S, Dermaut B, Goeman J, Saerens J, Marien P, Pickut B, et al. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2003;74(8):1148–51.
IEEE
[1]
S. Engelborghs et al., “Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects,” JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, vol. 74, no. 8, pp. 1148–1151, 2003.
@article{3200783,
  abstract     = {{Objective: The authors conducted a prospective study of neurodegenerative and vascular dementia in Belgium. Strict diagnostic inclusion criteria were used to include well defined patients and controls. The results of apolipoprotein E (APOE) genotype effect on risk and clinical characteristics are presented. 
Methods: APOE genotyping was performed in patients with probable Alzheimer's disease (AD) (n=504), frontotemporal dementia (FTD) (n=47), vascular dementia (VaD) (n=152), mixed dementia (n=132), mild cognitive impairment (MCI) (n=44), Parkinson's disease (PD) (n=30), dementia with Lewy bodies (DLB) (n=17), and multisystem atrophy (MSA)/progressive supranuclear palsy (PSP) (n=12). 
Results: The APOE allele frequencies of this Belgian control population (epsilon2: 6.9%; epsilon3: 76.2%; epsilon4: 16.9%) did not differ from those reported for other white populations. AD, MCI, and mixed dementia patients had higher APOE epsilon4 (32.9%, 38.6%, and 28.4% respectively) and lower APOE epsilon3 (62.2%, 53.4%, and 66.3%) frequencies compared with controls, whereas only AD and mixed dementia patients had lower APOE epsilon2 frequencies (4.9% and 5.3%). Apart from a borderline significant different distribution of APOE allele frequencies in VaD patients compared with controls, no other differences were detected. The influence of APOE epsilon4 on clinical features of dementia was limited to lower age at onset in AD patients and a less pronounced negative correlation between age at onset and number of epsilon4 alleles in MCI and mixed dementia patients. 
Conclusions: This study confirmed the risk association between APOE epsilon4 and AD. The observation that APOE epsilon4 is associated with mixed dementia reflected the role of AD in the aetiopathogenesis of this condition. Although MCI is an aetiologically heterogeneous syndrome, the increased APOE epsilon4 frequencies indicated that a large proportion of the MCI patients included in the study might be predisposed to develop AD.}},
  author       = {{Engelborghs, S and Dermaut, Bart and Goeman, J and Saerens, J and Marien, P and Pickut, BA and Van den Broeck, M and Serneels, S and Cruts, M and Van Broeckhoven, C and De Deyn, PP}},
  issn         = {{0022-3050}},
  journal      = {{JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY}},
  keywords     = {{ONSET ALZHEIMERS-DISEASE,APOLIPOPROTEIN-E EPSILON-4,FRONTOTEMPORAL DEMENTIA,E4 ALLELE,E GENE,RISK,ASSOCIATION,DECLINE,AGE}},
  language     = {{eng}},
  number       = {{8}},
  pages        = {{1148--1151}},
  title        = {{Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects}},
  url          = {{http://doi.org/10.1136/jnnp.74.8.1148}},
  volume       = {{74}},
  year         = {{2003}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: